Treat resistant bacterial infections in respiratory and urinary tracts
Availability
In Stock
Jackspor-CV 375 is a powerful antibiotic tablet combining Cefixime, a third-generation cephalosporin, with Clavulanic Acid, a beta-lactamase inhibitor. This combination treats a wide range of resistant bacterial infections, especially of the respiratory, urinary, and ENT systems. Clavulanic acid enhances the effectiveness of Cefixime against beta-lactamase-producing organisms.
Key Points: Contains Cefixime 200 mg and Clavulanic Acid 125 mg Effective against resistant respiratory, UTI, and ENT infections Enhanced spectrum due to beta-lactamase inhibition
Find products similar to Cefixime 200 Mg + Potassium Clavulanate 125 Mg Tablets
At Moulins Pharmaceuticals, we believe that healthcare goes beyond medicine. Rooted in compassion and guided by innovation, we offer not just pharmaceutical products—but trusted partnerships and meaningful care. Inspired by the natural power of a "moulin"—a small yet vital channel that sustains ecosystems—we aim to be a force of healing that flows through every stage of life.
We are not a PCD company. We represent a new model of ethical pharma, built on quality, trust, and long-term vision. Our operations are patient-centric, brand-focused, and committed to transforming how healthcare reaches people—genuinely and holistically.
✅ What We Offer
Diverse Therapeutic Portfolio: Covering key specialities like General Medicine, Paediatrics, Gynaecology, Dermatology, Orthopaedics, Cardiac-Diabetic Care, Gastroenterology, Neuro-Psychiatry, and Nutraceuticals.
Trademark-Protected Brands: Every product name is TM (trademark) protected, securing brand value and ensuring future-ready business.
Premium Visual Identity: Creative, thoughtfully designed packaging and visual aids crafted by our in-house team—reflecting empathy, care, and reliability.
Ethical Business Collaborations: We work with like-minded partners who share our commitment to quality—not quantity. (#NotaPCDCompany)
Transparent and Reliable Operations: No hidden costs. No inflated expectations. Just real partnerships and mutual growth.
Patient-First Vision: More than commerce, our goal is to build a healthier tomorrow—one relationship, one product, one life at a time.
